Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $8.2 million.

  • Pyxis Oncology's Cash from Investing Activities rose 143487.50% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year change of. This contributed to the annual value of $8.2 million for FY2024, which is 107.78% up from last year.
  • As of FY2024, Pyxis Oncology's Cash from Investing Activities stood at $8.2 million, which was up 107.78% from -$104.8 million recorded in FY2023.
  • In the past 5 years, Pyxis Oncology's Cash from Investing Activities registered a high of $8.2 million during FY2024, and its lowest value of -$104.8 million during FY2023.
  • In the last 3 years, Pyxis Oncology's Cash from Investing Activities had a median value of -$6.4 million in 2022 and averaged -$34.4 million.
  • In the last 5 years, Pyxis Oncology's Cash from Investing Activities crashed by 1,538.52% in 2023 and then surged by 107.78% in 2024.
  • Over the past 5 years, Pyxis Oncology's Cash from Investing Activities (Yearly) stood at -$1.5 million in 2020, then skyrocketed by 60.22% to -$590,000 in 2021, then plummeted by 984.58% to -$6.4 million in 2022, then plummeted by 1,538.52% to -$104.8 million in 2023, then soared by 107.78% to $8.2 million in 2024.